Centro Studi GISED
Change language 
Systematic review of studies quality on COVID-19 risks in clinical subgroups
What we do
This is a systematic review of the quality of published studies concerning the risks of COVID-19 in potentially high-risk clinical subgroups, such as patients on biological drug therapy, organ transplant recipients and patients on immunosuppressive therapy.
Back to research project
